Ledger.Open graph →

SEC Form D · filed July 28, 2017

BioMedomics, Inc

Offering

$2.7M

Sold

$530K

Exemption

Rule 506(b)

Industry

Biotechnology

Location

RESEARCH TRIANGLE PARK, NC

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Cam Patterson · RESEARCH TRIANGLE PARK, NCDirector Frank Wang · RESEARCH TRIANGLE PARK, NCExec · Director Lin Wu · RESEARCH TRIANGLE PARK, NCDirector Tom Roberg · RESEARCH TRIANGLE PARK, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗